BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3375961)

  • 41. Data on first recurrence after treatment for malignant melanoma in a large patient population.
    Fusi S; Ariyan S; Sternlicht A
    Plast Reconstr Surg; 1993 Jan; 91(1):94-8. PubMed ID: 8416544
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Malignant melanoma in children.
    Davidoff AM; Cirrincione C; Seigler HF
    Ann Surg Oncol; 1994 Jul; 1(4):278-82. PubMed ID: 7850525
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumour thickness and the site and time of first recurrence in cutaneous malignant melanoma (stage I).
    Milton GW; Shaw HM; Farago GA; McCarthy WH
    Br J Surg; 1980 Aug; 67(8):543-6. PubMed ID: 7427045
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Follow-up of malignant melanoma].
    Truchetet F; Chartier C; Heid E
    Ann Dermatol Venereol; 1989; 116(5):437-40. PubMed ID: 2675740
    [No Abstract]   [Full Text] [Related]  

  • 45. Late recurrence of stage I malignant melanoma.
    Gutman M; Klausner JM; Inbar M; Rozin RR
    J Surg Oncol; 1989 Oct; 42(2):96-8. PubMed ID: 2796353
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Significance of histological findings in the prognosis of malignant melanoma. Findings in 253 melanoma patients followed for 5 years].
    Gartmann H; Tritsch H
    Dtsch Med Wochenschr; 1972 Jun; 97(22):857-9. PubMed ID: 5032178
    [No Abstract]   [Full Text] [Related]  

  • 47. Follow-up of early stage melanoma: specialist clinician perspectives on the functions of follow-up and implications for extending follow-up intervals.
    Rychetnik L; McCaffery K; Morton RL; Thompson JF; Menzies SW; Irwig L
    J Surg Oncol; 2013 Apr; 107(5):463-8. PubMed ID: 23090908
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lack of predictive factors in late recurrence of stage I melanoma.
    Tahery DP; Moy RL
    Int J Dermatol; 1992 Sep; 31(9):629-31. PubMed ID: 1459759
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Judging prognosis in malignant melanoma of the skin. A problem of inference over small data sets.
    Blois MS; Sagebiel RW; Tuttle MS; Caldwell TM; Taylor HW
    Ann Surg; 1983 Aug; 198(2):200-6. PubMed ID: 6870378
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Control of cutaneous melanoma].
    Nyfors A
    Tidsskr Nor Laegeforen; 1992 Jun; 112(17):2225. PubMed ID: 1523664
    [No Abstract]   [Full Text] [Related]  

  • 51. Late relapse from cutaneous stage I malignant melanoma.
    Shaw HM; Beattie CW; McCarthy WH; Milton GW
    Arch Surg; 1985 Oct; 120(10):1155-9. PubMed ID: 4038058
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Follow-up recommendations for patients with stage I malignant melanoma.
    Romero JB; Stefanato CM; Kopf AW; Bart RS
    J Dermatol Surg Oncol; 1994 Mar; 20(3):175-8. PubMed ID: 8151030
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Late recurrence of localized cutaneous melanoma: its influence on follow-up policy.
    McEwan L; Smith JG; Matthews JP
    Plast Reconstr Surg; 1990 Sep; 86(3):527-34. PubMed ID: 2385670
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patients' perspectives of long-term follow-up for localised cutaneous melanoma.
    Morton RL; Rychetnik L; McCaffery K; Thompson JF; Irwig L
    Eur J Surg Oncol; 2013 Mar; 39(3):297-303. PubMed ID: 23287820
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The influence of resection margin on prognosis in clinical stage I malignant melanoma of the lower leg.
    Elberg JJ; Poulsen H; Ladefoged C
    Scand J Plast Reconstr Surg Hand Surg; 1989; 23(1):59-63. PubMed ID: 2740849
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Follow-up in patients with localised primary cutaneous melanoma.
    Francken AB; Bastiaannet E; Hoekstra HJ
    Lancet Oncol; 2005 Aug; 6(8):608-21. PubMed ID: 16054572
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Follow-up requirements for thick cutaneous melanoma.
    Sylaidis P; Gordon D; Rigby H; Kenealy J
    Br J Plast Surg; 1997 Jul; 50(5):349-53. PubMed ID: 9245869
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy.
    Garbe C; Paul A; Kohler-Späth H; Ellwanger U; Stroebel W; Schwarz M; Schlagenhauff B; Meier F; Schittek B; Blaheta HJ; Blum A; Rassner G
    J Clin Oncol; 2003 Feb; 21(3):520-9. PubMed ID: 12560444
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Surveillance and follow-up examinations in cutaneous melanoma.
    Garbe C; Schadendorf D
    Onkologie; 2003 Jun; 26(3):241-6. PubMed ID: 12845208
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The wide and deep excision of primary malignant melanoma: a dogma on the decline.
    Piérard-Franchimont C; Piérard GE
    Acta Clin Belg; 1998 Apr; 53(2):98-9. PubMed ID: 9639947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.